Echo Laboratories Financing
Echo Laboratories, Inc., Corporation just had published form D for $2.00 million debt financing. This is a new filing. Echo Laboratories was able to finance itself with $1.78 million. That is 88.91% of the financing offer. The total private offering amount was $2.00 million. The private financing document was filed on 2016-11-08. The reason for the financing was: unspecified. The fundraising still has about $221,900 more and is not closed yet. We have to wait more to see if the offering will be fully taken.
Echo Laboratories is based in Alabama. The company’s business is Other Health Care. The form was submitted by Eugene Cho Chief Executive Officer. The company was incorporated in 2013. The filler’s address is: 1202 Knoxville Street, San Diego, Ca, California, 92110. Eugene Cho is the related person in the form and it has address: C/O Echo Laboratories, Inc., 1202 Knoxville Street, San Diego, Ca, California, 92110. Link to Echo Laboratories Filing: 000168957816000001.
Analysis of Echo Laboratories Offering
On average, firms in the Other Health Care sector, sell 68.60% of the total offering amount. Echo Laboratories sold 88.91% of the offering. The fundraising is still open. Could this mean that the trust in Echo Laboratories is high? The average fundraising amount for companies in the Other Health Care industry is $1.16 million. The total amount raised is 53.28% bigger than the average for companies in the Other Health Care sector. The minimum investment for this offering is set at $0. If you know more about the reasons for the financing, please comment below.
What is Form D? What It Is Used For
Form D disclosures could be used to track and understand better your competitors. The information in Form D is usually highly confidential for ventures and startups and they don’t like revealing it. This is because it reveals amount raised or planned to be raised as well as reasons for the financing. This could help competitors. Entrepreneurs usually want to keep their financing a ‘secret’ so they can stay in stealth mode for longer.
Why Fundraising Reporting Is Good For Echo Laboratories Also
The Form D signed by Eugene Cho might help Echo Laboratories, Inc.’s sector. First, it helps potential customers feel more safe to deal with a firm that is well financed. The odds are higher that it will stay in the business. Second, this could attract other investors such as venture-capital firms, funds and angels. Third, positive PR effects could even bring leasing firms and venture lenders.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.